Summary

The global healthcare supply chain management market is projected to reach USD 5.06 billion by 2030 from USD 3.71 billion in 2024, at a CAGR of 6.4% during the forecast period. The market is expected to grow as strict regulatory and compliance demands encourage healthcare organizations to implement advanced supply chain management solutions to adhere to safety standards. Increasing healthcare expenses and the necessity for operational efficiency are also motivating the adoption of systems that enhance inventory management, minimize waste, and reduce operational costs. The shortage of skilled professionals managing complex supply chain systems makes implementation and operation more difficult. Additionally, the varying regional regulations also create challenges for internationally operating companies.

“The pharmaceutical & biotechnology segment is expected to register fastest growth during the forecast period, by product managed”
The healthcare supply chain management, by product managed segment, is segmented into pharmaceutical & biotechnology, medical devices & equipment, and others. The pharmaceutical & biotechnology segment is expected to grow the fastest during the forecast period due to the increasing demand for innovative drugs and vaccines driven by rising chronic diseases and an aging population. Advances in biotechnology, such as gene therapies and personalized medicine, add to the growth by creating complex supply chain needs. Additionally, increased concern to address global health issues combined with the imperative to quickly and compliantly distribute urgently needed medicines continues to facilitate this segment's growth.

“On-premise segment dominated the market in the healthcare supply chain management market, by deployment model in 2023.”’
By deployment model, the healthcare supply chain management market is divided into the on-premise models and cloud based models. In 2023, on-premise models accounted to hold a significant share of the healthcare supply chain management market, by deployment model. This segment's prominent position is due to the need to secure private and confidential data and control information workflow in the organization. The absence of incremental costs throughout the ownership of solutions compared to cloud-based deployment also drives the adoption of on-premises solutions. Additionally, internet penetration, ease of access, online documentation, the need for security requirements, and in-house hosting options are the key factors encouraging the growth of the on-premises healthcare supply chain management software market.

“Asia Pacific is expected to register the fastest market growth during the forecast period.”
The healthcare supply chain management market is bifurcated into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The Asia Pacific region is anticipated to experience the fastest growth during the forecast period. This rapid expansion can be attributed to government initiatives in the region focused on enhancing healthcare infrastructure and fostering digital transformation. This has resulted in the development of more efficient and resilient supply chains. India's National Digital Health Mission (NDHM) aims to create a strong digital health ecosystem that boosts accessibility, quality, and efficiency in healthcare delivery while enhancing healthcare supply chain management.

The break-down of primary participants is as mentioned below:
• By Company Type - Tier 1: 32%, Tier 2: 44%, and Tier 3: 24%
• By Designation - Directors: 30%, Manager: 34%, and Others: 36%
• By Region - North America: 40%, Europe: 28%, Asia Pacific: 20%, Latin America: 7% and Middle East & Africa: 5%

List of Companies Profiled in the Report
o Oracle (US)
o SAP SE (Germany)
o Infor (US)
o IBM (US)
o Mckesson Corporation (US)
o Tecsys Inc. (Canada)
o Global Healthcare Exchange, LLC. (US)
o Cardinal Health. (US)
o Corcentric, Inc. (US)
o Epicor Software Corporation (US)
o Coupa. (US)
o Manhattan Associates (US)
o Blue Yonder Group, Inc. (US)
o LogiTag Systems (US)
o Premier (US)
o Workday, Inc. (US)
o Arvato Systems (Germany)
o GEP (US)
o AmerisourceBergen Corporation. (US)
o Procurement Partners (US)
o Vizient Inc. (US)
o Jump Technologies, Inc. (US)
o inBeam Technologies. (US)
o ConnectSx (US)
Research Coverage:
The report analyzes the healthcare supply chain management market and aims to estimate the market size and future growth potential of various market segments based on offering, function, product managed, deployment model, end user, and region. The report also analyses factors (such as drivers, opportunities and challenges) affecting market growth. It evaluates the opportunities and challenges in the market for stakeholders. The report also studies micro markets with respect to their growth trends, prospects, and contributions to the total healthcare supply chain management market. The report forecasts the revenue of the market segments with respect to five major regions. The report also provides a competitive analysis of the key players operating in this market, along with their company profiles, product offerings, recent developments, and key market strategies.
Reasons to Buy the Report
This report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them garner a greater share of the market. Firms purchasing the report could use one or a combination of the below-mentioned strategies to strengthen their positions in the market.
This report provides insights on:
• Analysis of key drivers (increasing pressure on healthcare providers to improve operational efficiency and profitability, rising demand for healthcare services due to population growth and aging demographics, surging focus on cost reduction within the supply chain, demand for transparency and traceability, continuous support in the form of funding, investment, and partnerships, large scale drug counterfeiting in pharmaceutical industry), restraints (high implementation costs for advanced technologies, data security and privacy concerns), opportunities (adoption of advanced technologies like AI, IoT, and blockchain, expansion into emerging markets with growing healthcare demands, expansion of e-commerce in healthcare, enhanced focus on sustainability and eco-friendly practices in healthcare logistics), challenges (complex and varying regulatory requirements across regions, shortage of skilled professionals to manage sophisticated systems) are factors contributing the growth of the healthcare supply chain management market.
• Product Development/Innovation: Detailed insights on upcoming trends, research & development activities, and new software launches in the Healthcare supply chain management market.
• Market Development: Comprehensive information on the lucrative emerging markets, offering, function, product managed, deployment model, end user, and region.
• Market Diversification: Exhaustive information about the software portfolios, growing geographies, recent developments, investments in the healthcare supply chain management market.
• Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings, company evaluation quadrant, and capabilities of leading players in the global Healthcare supply chain management market such as Oracle (US), SAP SE (Germany), Infor (US), IBM (US), Cardinal Health (US).

ページTOPに戻る

Table of Contents

1 INTRODUCTION 42
1.1 STUDY OBJECTIVES 42
1.2 MARKET DEFINITION 42
1.3 STUDY SCOPE 43
1.3.1 SEGMENTS CONSIDERED & GEOGRAPHICAL SPREAD 43
1.3.2 INCLUSIONS & EXCLUSIONS 44
1.3.3 YEARS CONSIDERED 45
1.3.4 CURRENCY CONSIDERED 46
1.4 STAKEHOLDERS 46
1.5 SUMMARY OF CHANGES 47
2 RESEARCH METHODOLOGY 49
2.1 RESEARCH DATA 49
2.1.1 SECONDARY DATA 50
2.1.1.1 Key sources for secondary data 50
2.1.1.2 Key data from secondary sources 51
2.1.2 PRIMARY DATA 51
2.1.2.1 Key primary sources 52
2.1.2.2 Objectives of primary research 52
2.1.2.3 Key industry insights 53
2.2 MARKET SIZE ESTIMATION 54
2.2.1 REVENUE SHARE ANALYSIS 54
2.2.2 BOTTOM-UP APPROACH (END-USER ADOPTION) 55
2.2.3 COMPANY PRESENTATIONS AND PRIMARY INTERVIEWS 56
2.2.4 TOP-DOWN APPROACH 58
2.3 DATA TRIANGULATION 59
2.4 MARKET SHARE ESTIMATION 60
2.5 STUDY ASSUMPTIONS 61
2.6 RESEARCH LIMITATIONS 61
2.6.1 METHODOLOGY-RELATED LIMITATIONS 61
2.6.2 SCOPE-RELATED LIMITATIONS 61
2.7 RISK ASSESSMENT 62
3 EXECUTIVE SUMMARY 63
 
4 PREMIUM INSIGHTS 68
4.1 HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET OVERVIEW 68
4.2 NORTH AMERICA: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, BY END USER & COUNTRY (2023) 69
4.3 HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET: GEOGRAPHIC SNAPSHOT 70
4.4 REGIONAL MIX: HEALTHCARE SUPPLY CHAIN MANAGEMENT (2024−2030) 71
4.5 HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET: DEVELOPED VS. EMERGING MARKETS 71
5 MARKET OVERVIEW 72
5.1 INTRODUCTION 72
5.2 MARKET DYNAMICS 72
5.2.1 DRIVERS 74
5.2.1.1 Increasing pressure on healthcare providers to improve operational efficiency and profitability 74
5.2.1.2 Rising demand for healthcare services due to population growth and aging demographics 74
5.2.1.3 Focus on reducing supply chain costs 75
5.2.1.4 Demand for transparency and traceability 75
5.2.1.5 Availability of funding, investments, and partnerships 76
5.2.1.6 Large-scale drug counterfeiting in pharmaceutical industry 76
5.2.2 RESTRAINTS 77
5.2.2.1 High implementation costs for advanced technologies 77
5.2.2.2 Data security and privacy concerns 77
5.2.2.3 Supply chain disruptions due to global events or geopolitical tensions 78
5.2.3 OPPORTUNITIES 79
5.2.3.1 Increasing use of AI-powered solutions 79
5.2.3.2 Expansion into emerging markets with growing healthcare demands 79
5.2.3.3 Expansion of E-commerce in healthcare 80
5.2.3.4 Enhanced focus on sustainability and eco-friendly practices
in healthcare logistics 80
5.2.4 CHALLENGES 81
5.2.4.1 Complex and varying regulatory requirements across regions 81
5.2.4.2 Shortage of skilled professionals to manage sophisticated systems 82
5.3 TRENDS/DISRUPTIONS IMPACTING CUSTOMER’S BUSINESS 82
5.4 INDUSTRY TRENDS 83
5.4.1 ERP IN HEALTHCARE SUPPLY CHAIN MANAGEMENT SOLUTIONS 83
5.4.2 CLOUD-BASED SOLUTIONS 83
5.4.3 RISING STRATEGIC INITIATIVES AND INNOVATIONS BY KEY
INDUSTRY PLAYERS 84
5.5 ECOSYSTEM ANALYSIS 85
5.6 VALUE CHAIN ANALYSIS 88
5.7 TECHNOLOGY ANALYSIS 89
5.7.1 KEY TECHNOLOGIES 89
5.7.1.1 Blockchain 90
5.7.1.2 Artificial intelligence & machine learning 90
5.7.1.3 Cloud computing 90
5.7.2 COMPLEMENTARY TECHNOLOGIES 91
5.7.2.1 Data analytics 91
5.7.2.2 Internet of Things 91
5.7.3 ADJACENT TECHNOLOGIES 91
5.7.3.1 AR/VR 91
5.8 REGULATORY ANALYSIS 92
5.8.1 REGULATORY BODIES, GOVERNMENT AGENCIES, & OTHER ORGANIZATIONS 92
5.8.2 REGULATORY SCENARIO 95
5.8.3 INCREASING REGULATIONS AROUND CALIBRATION & CERTIFICATION 100
5.9 PRICING ANALYSIS 102
5.9.1 INDICATIVE PRICING OF SOLUTIONS, BY KEY PLAYER 102
5.9.2 AVERAGE SELLING PRICE, BY REGION (QUALITATIVE) 104
5.10 PORTER’S FIVE FORCES ANALYSIS 104
5.10.1 INTENSITY OF COMPETITIVE RIVALRY 106
5.10.2 BARGAINING POWER OF BUYERS 106
5.10.3 THREAT OF SUBSTITUTES 106
5.10.4 THREAT OF NEW ENTRANTS 106
5.10.5 BARGAINING POWER OF SUPPLIERS 106
5.11 KEY STAKEHOLDERS AND BUYING CRITERIA 107
5.11.1 KEY STAKEHOLDERS IN BUYING PROCESS 107
5.11.2 KEY BUYING CRITERIA 108
5.12 PATENT ANALYSIS 109
5.12.1 PATENT PUBLICATION TRENDS 109
5.12.2 JURISDICTION ANALYSIS: TOP APPLICANT COUNTRIES FOR HEALTHCARE SUPPLY CHAIN MANAGEMENT 109
5.12.3 MAJOR PATENTS IN HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET 110
5.13 END-USER ANALYSIS 113
5.13.1 UNMET NEEDS 113
5.13.2 END-USER EXPECTATIONS 113
5.14 KEY CONFERENCES & EVENTS, 2024–2025 114
5.15 CASE STUDY ANALYSIS 115
5.15.1 CASE STUDY 1: TRANSFORMING SUPPLY CHAIN AT DAYTON
CHILDREN’S HOSPITAL 115
5.15.2 CASE STUDY 2: OLYMPUS CORPORATION’S PATH TO EFFICIENT HEALTHCARE SUPPLY CHAIN MANAGEMENT 116
5.15.3 CASE STUDY 3: IMPROVING SUPPLY CHAIN EFFICIENCY BY OVERCOMING FORECASTING AND INVENTORY BARRIERS 116
5.16 INVESTMENT AND FUNDING SCENARIO 117
5.17 BUSINESS MODELS 117
5.18 TRADE ANALYSIS 118
5.18.1 IMPORT SCENARIO FOR HS CODE 847190 118
5.18.2 EXPORT SCENARIO FOR HS CODE 847190 119
5.19 IMPACT OF AI/GEN AI ON HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET 120
5.19.1 KEY USE CASES 121
5.19.2 CASE STUDIES OF AI/GENERATIVE AI IMPLEMENTATION 122
5.19.2.1 Case Study 1: Enhancing supply chain with AI solutions at NHS Blood and Transplant 122
5.19.2.2 Case Study 2: Leveraging AI for proactive infection prevention in hospitals 122
5.19.3 IMPACT OF AI/GEN AI ON INTERCONNECTED AND ADJACENT ECOSYSTEMS 123
5.19.3.1 Healthcare IT market 124
5.19.3.2 Supply chain management market 124
5.19.3.3 Healthcare analytics market 124
5.19.3.4 Cloud ERP market 124
5.19.4 USER READINESS AND IMPACT ASSESSMENT 125
5.19.4.1 User readiness 125
5.19.4.1.1 User A: Manufacturers 125
5.19.4.1.2 User B: Distributors 125
5.19.4.1.3 User C: Providers 125
5.19.4.2 Impact assessment 125
5.19.4.2.1 User A: Manufacturers 125
5.19.4.2.1.1 Implementation 125
5.19.4.2.1.2 Impact 126
5.19.4.2.2 User B: Distributors 126
5.19.4.2.2.1 Implementation 126
5.19.4.2.2.2 Impact 126
5.19.4.2.3 User C: Providers 126
5.19.4.2.3.1 Implementation 126
5.19.4.2.3.2 Impact 127
6 HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, BY OFFERING 128
6.1 INTRODUCTION 129
6.2 SOFTWARE 129
6.2.1 ENTIRE SUPPLY CHAIN SUITES 131
6.2.1.1 Need for end-to-end visibility and real-time insights to drive market growth 131
6.2.2 SUPPLY CHAIN PLANNING SOFTWARE 132
6.2.2.1 Need for effective and efficient supply chain planning to fuel market growth 132
6.2.3 SUPPLIER RELATIONSHIP MANAGEMENT (SRM) SOFTWARE 134
6.2.3.1 Benefit of enhanced supplier collaboration to drive segmental growth 134
6.2.4 SUPPLY CHAIN BUSINESS NETWORK MANAGEMENT SOFTWARE 135
6.2.4.1 Need for effective supply chain business network to boost market 135
6.2.5 SUPPLY CHAIN COST-TO-SERVE ANALYSIS SOFTWARE 136
6.2.5.1 Pressing need to cut costs and improve operational efficiency to drive growth 136
6.2.6 SUPPLY CHAIN ANALYTICS SOFTWARE 138
6.2.6.1 Advancements in artificial intelligence for data analytics to drive market growth 138
6.2.7 SUPPLY CHAIN VISIBILITY SOFTWARE 139
6.2.7.1 Greater visibility and maintenance across supply chain to drive market growth 139
6.3 HARDWARE 140
6.3.1 BARCODES & BARCODE SCANNERS 141
6.3.1.1 Need for better tracking and traceability of medical devices to drive market growth 141
6.3.2 SYSTEMS 142
6.3.2.1 Advantages of smart cabinets in effective inventory management to drive segment 142
6.3.3 RFID TAGS & READERS 144
6.3.3.1 Crucial role of RFIDs in asset tracking and inventory management to drive market growth 144
6.3.4 OTHER HARDWARE COMPONENTS 145
6.4 SERVICES 146
6.4.1 MANAGED SERVICES 147
6.4.1.1 Benefit of being able to focus on core business activities to drive demand for managed services 147
6.4.2 PROFESSIONAL SERVICES 149
6.4.2.1 Perks of running supply chains with expert advice to drive demand for professional services 149
7 HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, BY FUNCTION 151
7.1 INTRODUCTION 152
7.2 PURCHASING MANAGEMENT 152
7.2.1 SUPPLY MANAGEMENT 154
7.2.1.1 Growing investments in supplier relationship management to boost market 154
7.2.2 PROCUREMENT 155
7.2.2.1 Need for optimized data storage and management to accelerate growth 155
7.2.3 CAPITAL PURCHASING 157
7.2.3.1 Increasing use by equipment providers, suppliers, and facilitators to foster growth 157
7.2.4 STRATEGIC SOURCING 158
7.2.4.1 Rising inclination toward data-driven decision making to aid growth 158
7.2.5 TRANSPORTATION MANAGEMENT 159
7.2.5.1 Increasing demand for streamlined logistics operations to sustain growth 159
 
7.3 INVENTORY MANAGEMENT 161
7.3.1 ORDER MANAGEMENT 163
7.3.1.1 Need for automated order fulfillment process to promote growth 163
7.3.2 WAREHOUSE MANAGEMENT 164
7.3.2.1 Rise in advancements in warehouse design and labor management to drive market 164
7.3.3 CONSIGNMENT MANAGEMENT 166
7.3.3.1 Growing demand for reduced supply chain expenses to boost market 166
7.3.4 IMPLANT MANAGEMENT 167
7.3.4.1 Need to track and trace implants to promote growth 167
7.3.5 TISSUE MANAGEMENT 168
7.3.5.1 Expanding applications of human tissue implants to spur growth 168
8 HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, BY PRODUCT MANAGED 170
8.1 INTRODUCTION 171
8.2 PHARMACEUTICAL & BIOTECHNOLOGY PRODUCTS 171
8.2.1 SMALL-MOLECULE DRUGS 173
8.2.1.1 Need for efficient logistics to ensure timely delivery of small-molecule drugs to boost adoption of supply chain solutions 173
8.2.2 VACCINES 175
8.2.2.1 Need for robust infrastructure and advanced tracking systems to drive market growth 175
8.2.3 MONOCLONAL ANTIBODIES, BIOSIMILARS, AND MRNAS 177
8.2.3.1 New supply chain requirements fueled by ongoing advancements in biotechnology to support market growth 177
8.2.4 CELL & GENE THERAPY (CGT) PRODUCTS 178
8.2.4.1 Driving innovation in cell & gene therapy through strategic supply chain solutions to boost market 178
8.2.5 OTHER PHARMACEUTICAL & BIOTECHNOLOGY PRODUCTS 180
8.3 MEDICAL DEVICES & EQUIPMENT 181
8.3.1 SURGICAL INSTRUMENTS 182
8.3.1.1 Advancing surgical care through enhanced management of surgical instruments and logistics to contribute to growth 182
8.3.2 DIAGNOSTIC & THERAPEUTIC EQUIPMENT 184
8.3.2.1 Need for robust supply chain to handle complexities in diagnostic & therapeutic equipment to boost growth 184
8.3.3 MONITORING DEVICES 185
8.3.3.1 Growing need for effective supply chain management of monitoring devices to fuel growth 185
8.3.4 IMPLANTS & PROSTHETICS 187
8.3.4.1 Requirement of specialized manufacturing, sterilization, and distribution processes to propel market 187
8.3.5 OTHER MEDICAL DEVICES & EQUIPMENT 188
8.4 OTHER PRODUCTS MANAGED 189
9 HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET,
BY DEPLOYMENT MODEL 190
9.1 INTRODUCTION 191
9.2 ON-PREMISE MODELS 191
9.2.1 GROWING REQUIREMENT FOR DATA PRIVACY AND SECURITY TO DRIVE MARKET 191
9.3 CLOUD-BASED MODELS 193
9.3.1 NEED FOR COST-EFFECTIVE DATA SHARING TO STIMULATE GROWTH 193
10 HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, BY END USER 195
10.1 INTRODUCTION 196
10.1.1 MANUFACTURERS 196
10.1.1.1 Medical & surgical device manufacturers 198
10.1.1.1.1 Growing demand for advanced medical technologies to drive market 198
10.1.1.2 Pharmaceutical & biotechnology companies 199
10.1.1.2.1 Need to adhere to stringent regulatory requirements to augment growth 199
10.1.2 DISTRIBUTORS 201
10.1.2.1 Primary pharmaceutical distributors 202
10.1.2.1.1 Increasing focus on risk mitigation to speed up growth 202
10.1.2.2 Wholesalers 203
10.1.2.2.1 Growing complexity of global supply chain to fuel market 203
10.1.2.3 Group purchasing organizations 205
10.1.2.3.1 Rising need for simplified procurement process
to favor growth 205
10.1.3 HEALTHCARE PROVIDERS 206
10.1.3.1 Hospitals & clinics 208
10.1.3.1.1 Rising demand for improved patient outcomes
to facilitate growth 208
10.1.3.2 Pharmacies 210
10.1.3.2.1 Increasing reliance on barcode scanning and integrated software systems to aid growth 210
10.1.3.3 Ambulatory surgical centers 211
10.1.3.3.1 Need for effective inventory management to encourage growth 211
10.1.3.4 Other healthcare providers 212
 
11 HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, BY REGION 214
11.1 INTRODUCTION 215
11.2 NORTH AMERICA 215
11.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA 217
11.2.2 US 224
11.2.2.1 Growing collaborations among market players to drive market 224
11.2.3 CANADA 232
11.2.3.1 Increasing adoption of digital technologies to promote growth 232
11.3 EUROPE 240
11.3.1 MACROECONOMIC OUTLOOK FOR EUROPE 241
11.3.2 GERMANY 248
11.3.2.1 Booming medical device market to propel market 248
11.3.3 UK 256
11.3.3.1 Growing health service initiatives by government bodies
to drive market 256
11.3.4 FRANCE 264
11.3.4.1 Evolving digital health landscape to augment growth 264
11.3.5 SPAIN 272
11.3.5.1 Rise in chronic diseases to encourage growth 272
11.3.6 ITALY 280
11.3.6.1 Increasing initiatives in pharmaceutical and healthcare sectors
to aid growth 280
11.3.7 NORDIC COUNTRIES 287
11.3.7.1 Rising healthcare expenditure to facilitate growth 287
11.3.8 REST OF EUROPE 295
11.4 ASIA PACIFIC 303
11.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC 303
11.4.2 JAPAN 312
11.4.2.1 Dominant aging population to accelerate growth 312
11.4.3 CHINA 320
11.4.3.1 Expanding healthcare infrastructure to fuel market 320
11.4.4 INDIA 328
11.4.4.1 Increasing healthcare access to spur growth 328
11.4.5 REST OF ASIA PACIFIC 336
11.5 LATIN AMERICA 344
11.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA 344
11.5.2 BRAZIL 351
11.5.2.1 Growing modernization efforts to propel market 351
11.5.3 MEXICO 360
11.5.3.1 Growing foreign investment to boost market 360
11.5.4 REST OF LATIN AMERICA 367
 
11.6 MIDDLE EAST & AFRICA 374
11.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA 375
11.6.2 GCC COUNTRIES 382
11.6.2.1 Rising healthcare investments to facilitate growth 382
11.6.3 REST OF MIDDLE EAST & AFRICA 390
12 COMPETITIVE LANDSCAPE 398
12.1 INTRODUCTION 398
12.2 KEY PLAYER STRATEGY/RIGHT TO WIN 398
12.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET 398
12.3 REVENUE ANALYSIS, 2019–2023 402
12.4 MARKET SHARE ANALYSIS, 2023 403
12.4.1 RANKING OF KEY MARKET PLAYERS 406
12.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023 406
12.5.1 STARS 406
12.5.2 EMERGING LEADERS 406
12.5.3 PERVASIVE PLAYERS 406
12.5.4 PARTICIPANTS 407
12.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023 408
12.5.5.1 Company footprint 408
12.5.5.2 Region footprint 409
12.5.5.3 Offering footprint 410
12.5.5.4 Function footprint 411
12.5.5.5 End-user footprint 412
12.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023 413
12.6.1 PROGRESSIVE COMPANIES 413
12.6.2 RESPONSIVE COMPANIES 413
12.6.3 DYNAMIC COMPANIES 413
12.6.4 STARTING BLOCKS 413
12.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023 415
12.7 COMPANY VALUATION & FINANCIAL METRICS 416
12.7.1 FINANCIAL METRICS 416
12.7.2 COMPANY VALUATION 417
12.8 BRAND/PRODUCT COMPARISON 418
12.9 COMPETITIVE SCENARIO 419
12.9.1 SOLUTION/SERVICE LAUNCHES & ENHANCEMENTS 419
12.9.2 DEALS 420
12.9.3 EXPANSIONS 421
 
13 COMPANY PROFILES 423
13.1 KEY PLAYERS 423
13.1.1 SAP SE 423
13.1.1.1 Business overview 423
13.1.1.2 Products/Services/Solutions offered 424
13.1.1.3 Recent developments 426
13.1.1.3.1 Solution enhancements 426
13.1.1.4 MnM view 426
13.1.1.4.1 Right to win 426
13.1.1.4.2 Strategic choices 427
13.1.1.4.3 Weaknesses & competitive threats 427
13.1.2 ORACLE 428
13.1.2.1 Business overview 428
13.1.2.2 Products/Services/Solutions offered 429
13.1.2.3 Recent developments 430
13.1.2.3.1 Solution enhancements 430
13.1.2.3.2 Deals 431
13.1.2.3.3 Expansions 431
13.1.2.4 MnM view 431
13.1.2.4.1 Right to win 431
13.1.2.4.2 Strategic choices 432
13.1.2.4.3 Weaknesses & competitive threats 432
13.1.3 IBM 433
13.1.3.1 Business overview 433
13.1.3.2 Products/Services/Solutions offered 434
13.1.3.3 Recent developments 435
13.1.3.3.1 Deals 435
13.1.3.4 MnM view 436
13.1.3.4.1 Right to win 436
13.1.3.4.2 Strategic choices 437
13.1.3.4.3 Weaknesses & competitive threats 437
13.1.4 CARDINAL HEALTH 438
13.1.4.1 Business overview 438
13.1.4.2 Products/Services/Solutions offered 439
13.1.4.3 Recent developments 442
13.1.4.3.1 Deals 442
13.1.4.3.2 Expansions 444
13.1.4.4 MnM view 445
13.1.4.4.1 Right to win 445
13.1.4.4.2 Strategic choices 445
13.1.4.4.3 Weaknesses & competitive threats 445
 
13.1.5 INFOR (KOCH INDUSTRIES) 446
13.1.5.1 Business overview 446
13.1.5.2 Products/Services/Solutions offered 446
13.1.5.3 Recent developments 448
13.1.5.3.1 Deals 448
13.1.5.4 MnM view 449
13.1.5.4.1 Right to win 449
13.1.5.4.2 Strategic choices 449
13.1.5.4.3 Weaknesses & competitive threats 449
13.1.6 MANHATTAN ASSOCIATES 450
13.1.6.1 Business overview 450
13.1.6.2 Products/Services/Solutions offered 451
13.1.7 TECSYS INC. 454
13.1.7.1 Business overview 454
13.1.7.2 Products/Services/Solutions offered 455
13.1.7.3 Recent developments 457
13.1.7.3.1 Solution enhancements 457
13.1.7.3.2 Deals 457
13.1.8 GLOBAL HEALTHCARE EXCHANGE, LLC 459
13.1.8.1 Business overview 459
13.1.8.2 Products/Services/Solutions offered 459
13.1.8.3 Recent developments 462
13.1.8.3.1 Service/Solution launches & enhancements 462
13.1.8.3.2 Deals 463
13.1.8.3.3 Expansions 464
13.1.9 EPICOR SOFTWARE CORPORATION 465
13.1.9.1 Business overview 465
13.1.9.2 Products/Services/Solutions offered 465
13.1.9.3 Recent developments 467
13.1.9.3.1 Software launches 467
13.1.9.3.2 Deals 468
13.1.10 CORCENTRIC, INC. 470
13.1.10.1 Business overview 470
13.1.10.2 Products/Services/Solutions offered 470
13.1.10.3 Recent developments 471
13.1.10.3.1 Deals 471
13.1.11 MCKESSON CORPORATION 473
13.1.11.1 Business overview 473
13.1.11.2 Products/Services/Solutions offered 474
13.1.11.3 Recent developments 476
13.1.11.3.1 Solution launches 476
13.1.11.3.2 Deals 476
13.1.12 COUPA 477
13.1.12.1 Business overview 477
13.1.12.2 Products/Services/Solutions offered 477
13.1.12.3 Recent developments 479
13.1.12.3.1 Solution launches 479
13.1.12.3.2 Deals 480
13.1.12.3.3 Expansions 480
13.1.13 BLUE YONDER GROUP, INC. (PANASONIC CORPORATION) 481
13.1.13.1 Business overview 481
13.1.13.2 Products/Services/Solutions offered 482
13.1.13.3 Recent developments 484
13.1.13.3.1 Product enhancements 484
13.1.13.3.2 Deals 485
13.1.14 LOGITAG SYSTEMS 486
13.1.14.1 Business overview 486
13.1.14.2 Products/Services/Solutions offered 486
13.1.15 PREMIER 488
13.1.15.1 Business overview 488
13.1.15.2 Products/Services/Solutions offered 489
13.1.15.3 Recent developments 490
13.1.15.3.1 Solution launches 490
13.1.15.3.2 Deals 491
13.1.16 WORKDAY, INC. 494
13.1.16.1 Business overview 494
13.1.16.2 Products/Services/Solutions offered 495
13.1.16.3 Recent developments 496
13.1.16.3.1 Solution launches 496
13.1.16.3.2 Deals 497
13.1.17 ARVATO SE (BERTELSMANN SE & CO. KGAA) 498
13.1.17.1 Business overview 498
13.1.17.2 Products/Services/Solutions offered 499
13.1.17.3 Recent developments 501
13.1.17.3.1 Deals 501
13.1.18 CENCORA, INC. 502
13.1.18.1 Business overview 502
13.1.18.2 Products/Services/Solutions offered 503
13.1.18.3 Recent developments 504
13.1.18.3.1 Service launches 504
13.1.18.3.2 Deals 504
13.1.18.3.3 Expansions 505
 
13.1.19 GEP 507
13.1.19.1 Business overview 507
13.1.19.2 Products/Services/Solutions offered 508
13.1.19.3 Recent developments 510
13.1.19.3.1 Solution launches 510
13.1.19.3.2 Deals 510
13.1.19.3.3 Expansions 511
13.2 OTHER PLAYERS 512
13.2.1 JUMP TECHNOLOGIES, INC. 512
13.2.2 MEDSPHERE SYSTEMS CORPORATION 513
13.2.3 PROMEDEO 514
13.2.4 PROCUREMENT PARTNERS 515
13.2.5 VIZIENT INC. 516
13.2.6 INBEAM TECHNOLOGIES 517
13.2.7 CONNECTSX 518
14 APPENDIX 519
14.1 DISCUSSION GUIDE 519
14.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 524
14.3 CUSTOMIZATION OPTIONS 526
14.4 RELATED REPORTS 527
14.5 AUTHOR DETAILS 528